|Title:||Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan||Authors:||Yeh, Y.-T.
|Issue Date:||2017||Publisher:||PUBLIC LIBRARY SCIENCE||Journal Volume:||12||Journal Issue:||10||Source:||PLoS ONE||Abstract:||
Whether a low-density lipoprotein cholesterol (LDL-C) goal is essential in secondary prevention is still being debated. The aim of our study was to investigate whether achieving particular LDL-C level goals is associated with the reduction in the risk of major adverse cardiac events (MACEs) in patients with atherosclerotic cardiovascular diseases (ASCVD) on statin therapy.
|Appears in Collections:||臨床藥學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.